Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Bennett

Showing results (101-110 of 331) with videos related to

Pageof 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Heeding our words: complexities of research among low-literacy populationsMelissa A Simon, Xinqi Dong, Narissa Nonzee, et al.
Drug, Healthcare and Patient Safety|June 25, 2011
Beyond the black box: drug- and device-associated hypersensitivity eventsCharles L Bennett, Olatokunbo S Adegboro, Elizabeth A Calhoun, et al.
The New England Journal of Medicine|March 22, 2013
Colony-stimulating factors for febrile neutropenia during cancer therapyCharles L Bennett, Benjamin Djulbegovic, LeAnn B Norris, et al.
Drug Safety|September 26, 2025
Comment on: Association of GLP1-Receptor Agonists with Risk of Hepatocellular Carcinoma: A Retrospective Cohort StudyChien-Hsiang Weng, Philip A Chan, Joseph Magagnoli, et al.
Cancer Treatment and Research|November 30, 2022
Systemic Barriers and Potential Concerns from Reporting Serious Adverse Drug ReactionsMatthew A Taylor, Ashley C Godwin, Shamia Hoque, et al.
The Lancet. Oncology|January 5, 2017
Biosimilar and generic cancer drugs unlikely to bend cost curve in the USACharles L Bennett, Oliver A Sartor, James O Armitage, et al.
Best Practice & Research. Clinical Haematology|March 29, 2005
Clinical characteristics of erythropoietin-associated pure red cell aplasiaKenneth R Carson, Andrew M Evens, Charles L Bennett, et al.
Cancer|August 16, 2014
Reply to magnetic resonance imaging-based diagnosis of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma after therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximabCharles L Bennett, Scott D Newsome, Oliver Sartor, et al.
Cancer Treatment and Research|November 30, 2022
Fluoroquinolone-Associated Disability and Other Fluoroquinolone-Associated Serious Adverse Events: Unexpected Toxicities Have Emerged in Recent YearsCharles L Bennett, Oscar Champigneulle, Andrew Bennett, et al.
Cancer Treatment and Research|November 30, 2022
Was There Something Rotten in Denmark: Nephrogenic System Fibrosis Cases Occurring in CopenhagenCharles L Bennett, Bartlett Witherspoon, Kenneth R Carson, et al.
Pageof 34

Showing results (101-110 of 331) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Heeding our words: complexities of research among low-literacy populationsMelissa A Simon, Xinqi Dong, Narissa Nonzee, et al.
Drug, Healthcare and Patient Safety|June 25, 2011
Beyond the black box: drug- and device-associated hypersensitivity eventsCharles L Bennett, Olatokunbo S Adegboro, Elizabeth A Calhoun, et al.
The New England Journal of Medicine|March 22, 2013
Colony-stimulating factors for febrile neutropenia during cancer therapyCharles L Bennett, Benjamin Djulbegovic, LeAnn B Norris, et al.
Drug Safety|September 26, 2025
Comment on: Association of GLP1-Receptor Agonists with Risk of Hepatocellular Carcinoma: A Retrospective Cohort StudyChien-Hsiang Weng, Philip A Chan, Joseph Magagnoli, et al.
Cancer Treatment and Research|November 30, 2022
Systemic Barriers and Potential Concerns from Reporting Serious Adverse Drug ReactionsMatthew A Taylor, Ashley C Godwin, Shamia Hoque, et al.
The Lancet. Oncology|January 5, 2017
Biosimilar and generic cancer drugs unlikely to bend cost curve in the USACharles L Bennett, Oliver A Sartor, James O Armitage, et al.
Best Practice & Research. Clinical Haematology|March 29, 2005
Clinical characteristics of erythropoietin-associated pure red cell aplasiaKenneth R Carson, Andrew M Evens, Charles L Bennett, et al.
Cancer|August 16, 2014
Reply to magnetic resonance imaging-based diagnosis of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma after therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximabCharles L Bennett, Scott D Newsome, Oliver Sartor, et al.
Cancer Treatment and Research|November 30, 2022
Fluoroquinolone-Associated Disability and Other Fluoroquinolone-Associated Serious Adverse Events: Unexpected Toxicities Have Emerged in Recent YearsCharles L Bennett, Oscar Champigneulle, Andrew Bennett, et al.
Cancer Treatment and Research|November 30, 2022
Was There Something Rotten in Denmark: Nephrogenic System Fibrosis Cases Occurring in CopenhagenCharles L Bennett, Bartlett Witherspoon, Kenneth R Carson, et al.
Pageof 34